The board of EDX Medical Group plc has approved the issue of new ordinary shares, raising £3,500,000 for the company.

Existing high net worth shareholders have subscribed to the fundraising, it said.

EDX, listed on the AQSE index, develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases.